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Abstract
Background: Tajikistan has the highest incidence rate of tuberculosis (TB) in Central Asia. Its health system still
bears many features from Soviet times and is under-funded. Affordability is a major barrier to health care. Little is
known about health care seeking of TB patients in post-Soviet countries and their delay until the start of TB
therapy. The low estimated case detection rate in Tajikistan suggests major problems with access to care and
consequently long delays are likely.
Methods: The study investigated extent and determinants of patient and health system delays for TB. A
questionnaire was administered to a cohort of TB patients in twelve study districts representing a wide range of
conditions found in Tajikistan. Common patterns of health care seeking were analysed. Cox proportional hazards
models using eight predictor variables, including characteristics of health services delivery, were built to identify
determinants of patient and health system delays.
Results: Two-hundred-and-four TB patients were interviewed. A common pattern in treatment-seeking was visiting
a specialised TB facility at some stage. Typical delays until start of TB therapy were moderate and did not confirm
the expectation of long delays. Median patient, health system and total delays to TB treatment were 21.5, 16 and
52 days, respectively. None of the investigated predictors was significantly associated with patient delay. The type
of facility, where patients made their first contact with the health system, was the main determinant of health
system delay (p < 0.00005). We show for the first time that patients who had fallen ill and first presented to health
care in Russia had the longest delays. Those who first presented to peripheral primary care facilities also had
relatively long delays.
Conclusions: While overall delays were moderate, further improvement is needed for different subgroups. An
international referral system between Russia and Tajikistan to reduce delays of Tajik migrants who develop active
TB in Russia is urgently needed and would benefit both countries. Within Tajikistan, diagnostic pathways for
patients in the periphery should be shortened. To achieve this, strengthening of sputum smear examination
possibly including collection of sputa at peripheral primary care facilities may be needed.
Background
The tuberculosis (TB) incidence rate in Tajikistan is
estimated at 231 cases per 100’0 0 0p o p u l a t i o ni n2 0 0 7
[1]. The case detection rate ranges from 32% for sputum
smear positive cases to 39% for all cases. While the inci-
dence estimate from the national TB control program is
slightly lower (160 - 180 cases per 100’000), it is clear
that the TB epidemic is ravaging. Integration of the ver-
tical TB program rooted in the Soviet tradition with pri-
mary care is not yet complete. Historically, TB diagnosis
and treatment was the exclusive task of specialised TB
facilities and providers. The DOTS strategy was intro-
duced in two pilot districts in 2002 and by the end of
2007 has reached 100% coverage of Tajikistan. Under
DOTS, primary care providers also have the task of
diagnosing and treating TB. Despite insufficient funding,
the health system has been latching onto a dense net-
work of facilities with different levels of specialisation
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expenditure for health was less than US$2 per capita in
Tajikistan in 2003[2]. Health care workers are poorly
paid and informal payments are common [2,3]. Out-of-
pocket payments are an important barrier to access
health care services[4]. The policy in Tajikistan is to
provide anti-TB chemotherapy free of charge. Currently,
health reform is ongoing in order to strengthen primary
care under the name of Family Medicine[3].
It is estimated that up to a fifth of the population of
Tajikistan is working abroad, mainly in Russia, where
Tajik migrant workers are very vulnerable[5]. Albeit
labour migration has recently decreased due to the cur-
rent economic crisis and the loss of job opportunities in
Russia, remittances from labour migration are likely to
remain an important component of the Tajik economy.
TB control in low-income countries relies primarily on
treatment of active cases. A dose-response relationship
has been found between the delay to TB treatment and
the transmission to household members[6]. Conse-
quently, prompt start of treatment is of utmost impor-
tance. Passive case finding requires that patients present
to a health care facility and that health providers take
appropriate measures. Repeated referrals that do not
result in a diagnosis and effective treatment can frus-
trate patients, leading to delayed or missed diagnoses.
Storla et al[7] reviewed studies on delay to tuberculosis
treatment-defined as the period from onset of symptoms
until the start of treatment. They found that many fac-
tors can influence delay and that the same factor could
lead to shorter or longer delays in different settings. The
type of the first health care provider chosen often influ-
enced delay with findings relatively consistent among
studies: patients who first visited a traditional healer,
private provider, or a low-level government health facil-
ity had longer delays [8-16]. Poverty and rural residence
were almost invariably associated with longer delays[7].
Factors that often led to longer but sometimes also to
shorter delays were female sex and old age[7]. Despite
the specific traditions of TB control in the former Soviet
Union (FSU), no studies on the relationship between
health services delivery and delay in a post-Soviet coun-
try were found in the scientific literature. The only
study on delay from the FSU concentrated on stigma
and patient delay in Russia[17]. Investigating delay to
TB treatment in the FSU may contribute to the under-
standing of the devastating TB epidemic in this region.
The objective of the present study was to describe
common health care seeking behaviours of new pulmon-
ary TB patients in Tajikistan and to identify determi-
nants of delay based on the following explanatory
variables: sex, age, rural versus urban residence, district,
durable assets, labour migration to Russia, belief in cur-
ability of TB, use of self-treatment, sputum smear result,
and the type of facility first visited.
Methods
Study population
As DOTS expansion was under way in Tajikistan and in
order to produce meaningful evidence for the future, we
included only districts with an established DOTS pro-
gram (started in July 2006 at the latest) in the study.
Two regions were excluded because they were accessible
only by air at the time of the study, Badakhshan and
Sughd. Among the 24 remaining districts (’rayons’),
twelve were purposefully selected to represent urban,
rural, lowland and mountainous settings (figure 1).
Questionnaire and Interviews
All patients who fulfilled the inclusion criteria and who
were registered in the twelve study districts were
recruited into the study. Our inclusion criteria were:
enrolled for TB treatment in the period 1 December
Table 1 Characteristics of facilities in the Tajik health system§
Facility type Specialisation of
health worker†
Hospital
beds
Description
Medical House Nurse No Facility serving villages without a Rural Health Centre. Together with the latter forms
the peripheral primary care. Basic services from a nurse or a trained health worker.
Rural Health Centre Generalist/family
doctor
No° Facility serving mid-sized and larger villages. Stands at the centre of Family Medicine
and thus primary care. One or more family doctors and a number of nurses.
Polyclinic Specialist doctor No Facility found in district centres and larger towns. Specialist doctors provide
ambulatory services.
Central District Hospital Specialist doctor Yes Found in district centres. Specialist doctors provide in- and out-patient services.
Usually contains an ambulatory functioning like a Rural Health Centre.
District TB facility
(including TB hospitals)
TB specialist Partially Usually in the district centre. Often more than one in large districts. Part of the
historical vertical structure providing care for TB exclusively.
Republican Hospital Specialist doctor Yes Tertiary referral centres providing the most specialised services available.
Private clinic Varying Varying Exist only in large towns, mainly in the capital.
§This list is by no means complete, but contains the facilities of relevance to this study.
†This column shows the highest professional specialisation that is usually found at facilities of the respective type.
°Some Rural Health Centres are historically derived from rural hospitals with beds and in a transitional period may have hospital beds.
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case (sputum smear positive or negative) and at least 15
years old. Data for this study were collected alongside a
study on household costs of an episode of TB[18]. The
latter study included two interviews with each patient.
For the present study, only data from the first interview
were analysed. Patients were visited in hospital or at
their homes during the intensive phase of treatment,
written informed consent was obtained and a trained
interviewer administered a questionnaire. The question-
naire included detailed questions about the onset of
symptoms, health care seeking behaviour (including tra-
ditional healers and self-treatment), the timing of health
care seeking steps, diagnostic investigations that were
conducted and household assets. Onset of symptoms
was self-reported and concerned any symptoms likely to
be due to TB, most importantly cough. Patient delay
was defined as the period from onset of symptoms until
the first visit to a formal health care provider. Formal
health care providers included all the facilities listed in
table 1, but not traditional healers nor pharmacies, as
they are not allowed to diagnose and treat patients in
the Tajik health system. Health system delay was
defined as the time from the first visit to a formal health
care provider to the start of treatment.
Interviewers were trained during a fortnight before
conducting interviews on their own and were supervised
at least twice per month through joint interviews with
the main researcher. Specific emphasis was given to sup-
port the patients in their recall efforts, including the use
of a calendar of locally important events. Data were
entered in FileMaker (version 8.0v1, FileMaker Inc,
USA, 1984-2005).
Data Analysis
A l la n a l y s e sw e r ec o n d u c t e di nS t a t aI C / 1 0 . 1f o rM a c i n -
tosh (Stata Corporation, USA, 1985-2008). We carried
out a principal component analysis on 15 household
asset variables and three housing characteristics vari-
ables to construct a wealth index using a well estab-
lished and validated method [19,20]. The wealth index
Figure 1 Location of study districts among all districts with a DOTS program in July 2006 in Tajikistan. District codes: 1 = Tursunzoda, 2
= Shahrinaw, 3 = Hissor, 4 = Varzob, 5 = Rudaki, 6 = Danghara, 7 = Qurghonteppa, 8 = Vakhsh, 9 = Farkhor, 10 = Vose, 11 = Muminobod, 12 =
Shurobod.
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nomic status (SES).
For each patient, we listed every health care seeking
step and identified common patterns in the history of
health care seeking up to the start of anti-TB che-
motherapy. Particular attention was given to the timing
and the place of the sputum smear examination.
In order to investigate delay, we built Cox propor-
tional hazards models with delay as time-to-event. Two
separate models were built for patient and system delay,
because predictor variables are likely to differ. Sex, age
(categorised into four groups), residence, SES quintiles,
district, and labour migration were included in both
models. Belief in curability of TB and use of self-treat-
ment were included only in the model on patient delay.
Sputum smear status and the type of facility visited in
first instance were included only in the model for sys-
tem delay. Knowledge of symptoms was not included, as
the encounters with health care professionals could
change this variable between the times when it acts
(before the first visit to a formal provider) and when it
is measured (during treatment). We selected the best
model by subsequently excluding factors with p > 0.2 in
the likelihood-ratio test from the full model, until no
more factors could be excluded. The respective univari-
ate models were also built and the hazards ratios of fac-
tors were compared between univariate and multivariate
models in order to investigate potential confounding.
The present study has received approval from the
Ministry of Health of the Republic of Tajikistan in a
memorandum of understanding signed 18
th October
2006.
Results
Study population and health care seeking
The study identified 282 eligible patients, of whom 78
dropped out (table 2) and 204 were interviewed (table 3).
The patients who dropped out were virtually identical to
included patients in terms of the proportions of smear-
positive (60%in both cases) and male patients (54% versus
56%), but differed somewhat in their age-distribution and
in terms of residence. The proportion of patients who
were at least 45 years old was 36% among dropouts versus
16% amongst the study sample. The proportion of rural
patients was 79% versus 90%.
Self-treatment was used by 64 patients (31%) before the
start of anti-TB chemotherapy. A large variety of self-treat-
ments were used, ranging from honey and different herbs
over meat and fat of boar or dog to opium and allopathic
medicines. Self-treatment was used both before and after
the first visit to a formal health care provider. Only one
patient (0.5%) reported having visited a traditional healer
before the first visit to a formal health care provider and
four more patients did so after such visit.
The first formal health care facility approached was a
Rural Health Centre for 36 patients (18%), a central dis-
trict hospital for 39 patients (19%) and the district TB
facility for 41 (20%) patients (table 4). None of the study
subjects visited a private clinic. Each facility that was
visited was visited approximately twice on average (table
4, right-hand column). Patients made 4.8 (± s.e. 0.17)
visits to formal health care facilities on average before
anti-TB chemotherapy was started. It is noteworthy that
the district TB facilities were visited at some stage
before initiation of anti-TB chemotherapy by a large
majority (86%) of patients. Of the 28 patients who had
not visited their district TB facility, 15 lived in Danghara
district and all 15 had visited the Central District Hospi-
tal. In Danghara there was no separate TB facility as it
had already been integrated in the Central District
Hospital.
Delay
The median patient delay was 21.5 days (range: 0 to 410
days; mean: 45.7 days). Thirty-six patients were excluded
from the analysis of patient delay, because they reported
either no symptoms, a chronic pulmonary condition, or
because they were unable to assign at least an approxi-
mate date to both the onset of cough and the first visit
to a health care provider. The median reported system
delay was 16.0 days (0 to 339; 42.2). One patient was
excluded from the analysis of system delay because he
could not assign a date to the first visit to a formal pro-
vider. The median total delay from onset of cough until
start of anti-TB chemotherapy was 53 days (2 to 542;
81.8). Note that mean delays are not additive because of
the 36 patients excluded from analysis of patient delay,
but not system delay.
Determinants of Delay
None of the factors included in the model on patient
delay proved significant. Sex (hazards ratio women to
men 0.745, p = 0.103) and SES quintile (p = 0.132) were
retained in the final model (table 5). The final model on
system delay included the factors ‘first facility’ and ‘dis-
trict’ (table 6). The proportional hazards assumption
was not violated (based on Schoenfeld residuals, p =
Table 2 Reasons for dropout
Reason Number of cases (% of
drop-outs)
Wrong or insufficient address 18 (23)
Not found at home or in hospital
when visited
17 (22)
Died 5 (6)
Initial defaulter 3 (4)
Already in continuation phase when
visited
25 (32)
Did not consent 10 (13)
Total 78 (100)
Ayé et al. BMC Health Services Research 2010, 10:10
http://www.biomedcentral.com/1472-6963/10/10
Page 4 of 110.91). There was a striking relationship between first vis-
iting a district TB specialist and system delay: the med-
ian was six days versus 23 days for all other facilities
combined. Also, visiting first a Central District Hospital
was associated with a short system delay. Visiting first a
Medical House, Rural Health Centre, Polyclinic or a
facility in Russia was associated with longer system
delays. Patients who had first visited a health facility in
Russia had the longest system delays of all. It was found
that most patients were advised at the health facility in
Russia to travel to Tajikistan for treatment - often
already with a diagnosis or at least suspicion of TB. Sev-
eral patients reported that the Russian health system
made no treatment available to them.
I no r d e rt oc h e c kf o rp o t e n t i a lc o n f o u n d i n g ,t h e1 6
univariate models that are relevant to the above two
multivariate models were also computed. The univariate
models on patient delay showed consistent results with
all hazards ratios in the same direction and in a similar
range (table 7). Among the univariate models on health
s y s t e md e l a y( t a b l e8 ) ,t h ef a c t o r‘labour migration’
s h o w e das t r o n ga s s o c i a t i o ni nt h eu n i v a r i a t em o d e l
(hazards ratio 0.563, p = 0.006) but showed no signifi-
cant relationship (at the p = 0.2 level) in the multivariate
model and was consequently excluded.
Discussion
This study investigated the influence of health services
delivery rooted in the Soviet tradition of vertical TB
control programs on delay to TB treatment. To our
knowledge there have been no similar studies previously.
We found generally moderate delays in our study sam-
ple. Much longer delays for certain subgroups of
patients highlight the need for improvements in the
organisation of health services delivery. These improve-
ments include the implementation of an international
referral system between Russia and Tajikistan.
Limitations
As in any study on self-reported delay, there is potential
recall and reporting bias: patients might not remember
exactly (or even realise) when the first symptoms
started, thus they might report delay incorrectly. We
have tried to minimise recall and reporting bias by sup-
porting the interviewees in their recall work-among
Table 3 Demographic characteristics of study sample
Women Men Total
Profession n (%) n (%) n (%)
Unemployed 9 (10) 20 (18) 29 (14)
Student 4 (4) 12 (11) 16 (8)
Housewife 52 (58) 0 (0) 52 (25)
Retiree 5 (6) 2 (2) 7 (3)
Employee in industry 1 (1) 7 (6) 8 (4)
Employee in private service 0 (0) 2 (2) 2 (1)
Owner of business 0 (0) 0 (0) 0 (0)
Police 0 (0) 3 (3) 3 (1)
Health Care Worker 1 (1) 1 (1) 2 (1)
Civil service (other than police and health) 3 (3) 5 (4) 8 (4)
Petty Trader 3 (3) 19 (17) 22 (11)
Labour Migration to Russia 1 (1) 30 (26) 30 (15)
Farmer 11 (12) 13 (11) 24 (12)
Total 90 (100) 114 (100) 204 (100)
Age
15-24 y 34 (38) 44 (39) 78 (38)
25-34 y 23 (26) 40 (35) 63 (31)
35-44 y 16 (18) 14 (12) 30 (15)
45 y and older (max 72 y) 17 (19) 16 (14) 33 (16)
Total 90 (100) 114 (100) 204 (100)
Residence
Rural 79 (88) 105 (92) 184 (90)
Semi- or Peri-urban 3 (3) 8 (7) 11 (5)
Urban 8 (9) 1 (1) 9 (4)
Total 90 (100) 114 (100) 204 (100)
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training interviewers to be non-judgmental in the inqui-
ries about delay.
Residence broken up into the three levels rural, semi-
or peri-urban and urban, is a very approximate measure
of geographical accessibility. However, during the pilot
study patients could not give estimates of the distance
in kilometres from their place of residence to the near-
est health care facility. We therefore included residence
in our models on patient and system delays-a factor
which may include other information in addition to geo-
graphical accessibility. The small number of patients
from urban and peri-urban areas made it difficult to
detect statistical differences by residence. Medical
Houses and Rural Health Centres exist in very remote
places and it is likely that remoteness contributed to the
long delays found in patients who first visited one of
these two facility types. Residence, which was included
in the analysis, could only partly account for this
because many district centres (where a TB facility and a
hospital are situated) were also classified as rural.
The sample of patients for our study did not span a
full year. Consequently, we cannot exclude that delays
differ during other seasons.
It is possible that some patients went by without ever
being registered in the TB registry-for instance if
patients relied on self-treatment or informal providers
exclusively. The present study might consequently
underestimate some aspects of difficulty in access and
delay to TB treatment. This could affect our secondary
finding that this study did not find evidence of the very
strong barriers to access that might explain the low case
detection rate in Tajikistan. However, such underestima-
tion of difficulties in access is most likely for Tajik TB
patients in Russia, which would reinforce our findings if
anything.
Health care seeking
Patients in our study group made on average 4.8 visits
to a formal health care provider up to anti-TB che-
motherapy. This is more than the two to three visits
that the diagnostic pathway requires, namely two visits
to conduct sputum smear examination (usually at the
Table 4 Health care facility visited by TB patients
#patients visiting facility in first instance mean #visits (all patients) #visits among patients who visited§
Medical house 22 (10.8%) 0.23 1.88
Rural Health Centre 36 (17.7%) 0.45 2.04
Polyclinic 17 (8.3%) 0.28 2.19
Private clinic 0 (0.0%) 0.00 0.00
Central District Hospital 39 (19.1%) 0.83 1.77
Republican Hospital 15 (7.4%) 0.53 1.96
District TB facility 41 (20.1%) 1.86 2.16
Health facility in Russia 20 (9.8%) 0.25 2.60
Other facility† 14 (6.9%) 0.39 1.65
Sum 204 (100%) 4.83 N/A
§Mean number of visits among those patients who visited the respective facility.
†Including a health care facility reserved to staff of a large industrial company and Ministry of Defence facilities.
Table 5 Results of the multivariate Cox proportional hazards model on patient delay (n = 168)
Factor Hazards Ratio§ Lb95%CI† Ub95%CI° p-value
Male sex* 1.000 NA/ NA/ NA/
Female sex 0.745 0.523 1.061 0.103
SES quintile NA NA NA 0.132¶
SES quintile 1* 1.000 NA NA NA
SES quintile 2 0.661 0.409 1.067 0.090
SES quintile 3 1.045 0.645 1.694 0.859
SES quintile 4 0.614 0.365 1.032 0.065
SES quintile 5 0.712 0.432 1.174 0.183
§A hazards ratio >1 means a shorter delay, a hazards ratio <1 points to a longer delay relative to the comparison group.
†Lb95%CI = Lower boundary of 95%-confidence interval
°Ub95%CI = Upper boundary of 95%-confidence interval
*Comparison group
¶Based on log-likelihood ratio test
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the peripheral level, from where patients are referred.
However, it is less than what was found for example in
urban Zambia, where TB patients made 6.7 health care
visits on average[21].
In this study there was a lot of variability in the facil-
ity type, where the first contact with the health system
took place: eight of the nine facility types accounted for
a considerable proportion (6.9% or more) of first con-
tacts each. This is a broader variety than found by Mfi-
nanga et al[22] in Tanzania. Strikingly, almost all
patients visited the district TB facility at some time dur-
ing health care seeking. Especially primary care provi-
ders tend to refer patients to TB specialists rather than
diagnosing TB themselves. At the district TB facility,
usually both chest x-ray (CXR) and sputum smear
examination were conducted. Similar to a study in the
Philippines[23], we found that almost all patients had
had a CXR - despite national and international guide-
lines not requiring CXR for sputum smear positive
patients.
Eighty-six percent of patients reported a visit to the
TB specialist. Fifteen patients who did not report such
visit came from Danghara and had visited the Central
District Hospital there, which includes a TB ward.
Hence, the proportion of patients who have been seen
by a TB specialist is likely even higher than 86%.
The patients in our study sample reported very limited
use of informal providers. Social desirability bias could
be suspected. However, interviewees freely reported
their experiences in other areas where social desirability
bias could be suspected such as in the area of informal
payments. We therefore believe that social desirability
bias is not the reason for the low use of informal provi-
ders reported, but that TB patients in Tajikistan really
preferred formal health care providers.
Delay
Given the heavily resource-constrained setting, the total
delay found in this study is moderate. It is longer than
those reported in the Philippines and in China (median
delay of one month in both cases[15,23]), but much
shorter than found in studies in high-incidence settings,
where the median delay ranged from 80 to 120 days
[7,11-13,24]. This result is encouraging and to a certain
extent surprising. The estimated case detection rate
according to data of the World Health Organisation is
Table 6 Results of the multivariate Cox proportional hazards model on health system delay (n = 203)
Factor Hazards Ratio§ Lb95%CI† Ub95%CI° p-value
District NA NA NA 0.0191¶
Danghara* 1.000 NA NA N/A
Farkhor 0.917 0.490 1.716 0.786
Hissor 1.243 0.639 2.417 0.522
Muminobod 0.412 0.208 0.817 0.011
Qurghonteppa 1.502 0.623 3.623 0.365
Rudaki 1.516 0.837 2.744 0.170
Shahrinaw 1.293 0.291 5.738 0.735
Shurobod 1.335 0.600 2.968 0.479
Tursunzoda 0.966 0.509 1.835 0.916
Vakhsh 1.462 0.769 2.781 0.247
Varzob 0.953 0.334 2.720 0.928
Vose 0.879 0.488 1.584 0.669
First facility NA NA NA < 0.00005¶
District TB facility* 1.000 NA NA NA
Medical House 0.325 0.183 0.580 < 0.0005
Rural Health Centre 0.418 0.255 0.688 0.001
Polyclinic 0.409 0.216 0.773 0.006
Central District Hospital 0.704 0.435 1.136 0.151
Republican Hospital 0.646 0.341 1.226 0.181
Health facility in Russia 0.212 0.117 0.383 < 0.0005
Other facility‡ 0.365 0.185 0.721 0.004
§A hazards ratio >1 means a shorter delay, a hazards ratio <1 points to a longer delay relative to the comparison group.
†Lb95%CI = Lower boundary of 95%-confidence interval
°Ub95%CI = Upper boundary of 95%-confidence interval
¶Based on log-likelihood ratio test
*Comparison group
‡Including health care facilities reserved to staff of a large industrial company or the Ministry of Defence, respectively.
Ayé et al. BMC Health Services Research 2010, 10:10
http://www.biomedcentral.com/1472-6963/10/10
Page 7 of 11Table 7 Results of univariate Cox proportional hazards models on patient delay (n = 168)
Factor Hazards Ratio§ Lb95%CI† Ub95%CI° p-value
Male sex* 1.000 NA/ NA/ NA/
Female sex 0.834 0.613 1.136 0.250
Age NA/ NA/ NA/ 0.562
15-24 y* 1.000 NA/ NA/ NA/
25-34 y 0.870 0.598 1.265 0.466
35-44 y 0.827 0.527 1.299 0.409
45 y and older 0.728 0.458 1.157 0.179
Residence NA/ NA/ NA/ 0.831
Semi- or peri-urban* 1.000 NA/ NA/ NA/
Rural 0.903 0.459 1.777 0.767
Urban 0.751 0.288 1.961 0.559
SES quintile NA/ NA/ NA/ 0.221
SES quintile 1* 1.000 NA/ NA/ NA/
SES quintile 2 0.669 0.414 1.080 0.100
SES quintile 3 1.116 0.693 1.798 0.651
SES quintile 4 0.730 0.454 1.175 0.195
SES quintile 5 0.828 0.520 1.319 0.428
District NA/ NA/ NA/ 0.755
Danghara* 1.000 NA/ NA/ NA/
Farkhor 0.898 0.468 1.724 0.747
Hissor 0.639 0.315 1.297 0.215
Muminobod 1.023 0.496 2.111 0.95
Qurghonteppa 0.833 0.334 2.079 0.696
Rudaki 0.717 0.393 1.307 0.277
Shahrinaw 4.935 0.643 37.845 0.125
Shurobod 1.507 0.636 3.573 0.351
Tursunzoda 0.859 0.449 1.645 0.647
Vakhsh 0.751 0.390 1.446 0.392
Varzob 0.544 0.184 1.607 0.271
Vose 0.873 0.492 1.549 0.642
No migration* 1.000 NA/ NA/ NA/
Labour migration 0.889 0.565 1.400 0.612
Lack of belief in curability* 1.000 NA/ NA/ NA/
Belief in curability 1.121 0.827 1.518 0.462
No self-treatment* 1.000 NA/ NA/ NA/
Self-treatment 1.011 0.727 1.406 0.949
§A hazards ratio >1 means a shorter delay, a hazards ratio <1 points to a longer delay relative to the comparison group.
†Lb95%CI = Lower boundary of 95%-confidence interval
°Ub95%CI = Upper boundary of 95%-confidence interval
*Comparison group
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Variable Hazards Ratio§ Lb95%CI† Ub95%CI° p-value
Male sex* 1.000 NA/ NA/ NA/
Female sex 1.201 0.908 1.589 0.200
Age NA/ NA/ NA/ 0.270
15-24 y* 1.00 NA/ NA/ NA/
25-34 y 0.777 0.556 1.087 0.141
35-44 y 1.126 0.736 1.721 0.584
45 y and older 0.810 0.535 1.226 0.319
Residence NA/ NA/ NA/ 0.682
Semi- or periurban* 1.000 NA/ NA/ NA/
Rural 1.066 0.579 1.965 0.836
Urban 1.441 0.594 3.494 0.419
SES quintile NA/ NA/ NA/ 0.442
SES quintile 1* 1.000 NA/ NA/ NA/
SES quintile 2 0.946 0.608 1.471 0.804
SES quintile 3 1.004 0.646 1.558 0.987
SES quintile 4 0.781 0.501 1.219 0.277
SES quintile 5 1.205 0.779 1.865 0.402
District NA/ NA/ NA/ 0.368
Danghara* 1.000 NA/ NA/ NA/
Farkhor 1.043 0.564 1.930 0.892
Hissor 1.189 0.631 2.240 0.593
Muminobod 0.680 0.362 1.279 0.232
Qurghonteppa 1.725 0.734 4.052 0.211
Rudaki 1.553 0.895 2.694 0.118
Shahrinaw 0.857 0.201 3.653 0.835
Shurobod 1.418 0.650 3.092 0.380
Tursunzoda 1.284 0.696 2.368 0.423
Vakhsh 1.526 0.822 2.831 0.180
Varzob 1.311 0.495 3.472 0.586
Vose 1.180 0.684 2.038 0.551
No migration* 1.000 NA/ NA/ NA/
Labour migration 0.563 0.375 0.846 0.006
Sputum smear negative* 1.000 NA/ NA/ NA/
Sputum smear positive 1.153 0.870 1.530 0.322
First facility NA/ NA/ NA/ 0.0003
TB facility* 1.000 NA/ NA/ NA/
Medical House 0.425 0.249 0.724 0.002
Family Doctor 0.442 0.281 0.697 < 0.0005
Central District Hospital 0.768 0.492 1.196 0.243
Policlinic 0.562 0.317 0.996 0.049
Republican Hospital 0.613 0.338 1.111 0.107
Russia 0.302 0.175 0.524 < 0.0005
Other‡ 0.478 0.259 0.882 0.018
§A hazards ratio >1 means a shorter delay, a hazards ratio <1 points to a longer delay relative to the comparison group.
†Lb95%CI = Lower boundary of 95%-confidence interval
°Ub95%CI = Upper boundary of 95%-confidence interval
*Comparison group
‡Including health care facilities reserved to staff of a large industrial company or the Ministry of Defence, respectively.
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barriers to care and many of them remain undetected.
The reasonable median delay found in this study does
not necessarily support this view.
Determinants of delay
District and type of first facility visited were significant
determinants of health system delay. Muminobod is a
mountainous district and this may be one of the reasons
why treatment delays were longest there (cf. figure 1).
On the other hand, the similarly mountainous neigh-
bouring district of Shurobod was among the districts
with relatively short delays. Differences between districts
may account for a multitude of factors including differ-
ences in socio-economic conditions, accessibility, or
practices in the health centres in the district. The type
of the facility where the first formal health care contact
took place was the strongest predictor of system delay.
Visiting first a tertiary hospital or TB specialist is asso-
ciated with shorter delays. This is consistent with find-
ings from other settings, although there is considerable
variation[11-16,25]. Making the first visit to a Central
District Hospital was also significantly associated with
shorter delay. While a history of immigration has been
shown to influence delay in western countries [25,26],
this study shows for the first time that developing active
TB while being a temporary migrant worker abroad
leads to long system delays: patients who first visited a
facility in Russia had the longest delays of all. This is
not surprising given that these patients fell ill in Russia
and had to travel back to Tajikistan to start anti-TB
chemotherapy. About 10% of all TB patients receiving
treatment in the study area had developed active TB in
Russia. This may also be relevant for citizens of several
other Central Asian and Caucasian countries who
migrate to Russia to find work. The moderate delays of
many patients are encouraging, but improvements are
needed for patients first presenting to Medical Houses,
Rural Health Centres and especially facilities in Russia.
The consistent results of the univariate analyses com-
pared to the multivariate analysis support the view that
these results are not due to confounding. The factor
‘labour migration’ is an exception in the sense that it
shows a significant impact on health system delay in the
univariate but not in the multivariate analysis. There is
strong correlation between ‘labour migration’ and having
visited a facility in Russia. This does, however, not affect
our conclusions.
In order to reduce delays for Tajiks who develop
active TB while working in Russia, an international
referral system should be developed. The Russian TB
program and international organisations involved in TB
control in Russia should investigate the options of for-
eigners who develop TB while in Russia. If the situation
is as described by the patients in our study sample,
there are disincentives to early presentation to the Rus-
sian health system, because the patient cannot expect
treatment. Rather, presenting to the Russian health sys-
tem will mean that patients will have to spend money to
return to their home country. Such a disincentive is
likely to lead to delayed diagnosis and consequently to
extended periods of infectiousness in the community.
As mentioned above, most providers other than TB
specialists are reluctant of diagnosing TB and would
rather refer the patient. This is related to the vertical
TB control program inherited from the Soviet Union
and the resulting notion that TB patients should be
diagnosed and treated outside the general health ser-
vices. The large difference in the hazards ratios from the
peripheral facilities to the TB facility point at a need to
shorten referral pathways and referral times for TB
patients from the periphery. This needs to be achieved
without jeopardizing the short delays that patients
experience at the TB facilities. A good possibility would
be the diagnosis of TB in the peripheral facilities with-
out referral. At least for part of the districts, a sputum
collection plan exists, whereby peripheral facilities are
required to collect three sputa from a TB suspect and
then organise transport to the district TB facility, where
microscopic examination is conducted. Due to the
Soviet tradition of over-reliance on CXR and to doubts
about accuracy of sputum smear microscopy, sputum
collection at the periphery hardly ever takes place.
Lönnroth et al[27] have pointed out that the perceived
financial consequences of seeking health care affect the
decision of whether and when to initiate health care
seeking. Community members, TB patients and health
care providers in four districts of Tajikistan identified
financial costs of health care seeking as the main obsta-
cle to obtaining a diagnosis and treatment[28]. Conse-
quently, a better understanding of illness-related costs
and resulting mitigation strategies may also contribute
to shorter delays.
Conclusions
Before being diagnosed, TB patients visit a broad range
of different health facilities. While the median total
delay until start of treatment is moderate for most
patients, improvements are needed for certain sub-
groups. Those patients who develop TB while working
in Russia have the longest health system delays. Those
who first present to peripheral primary care facilities or
polyclinics have long system delays, too. Improvements
for both subgroups are possible through better organisa-
tion of health care delivery. An international referral
system for migrant workers developing active TB in
Russia is urgently needed and is in the interest of both
countries. Primary care providers should be enabled and
encouraged to diagnose TB and start patients on
Ayé et al. BMC Health Services Research 2010, 10:10
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Page 10 of 11treatment. Strengthening of sputum smear examination
and collection of specimens at primary care facilities
should be considered.
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